146 related articles for article (PubMed ID: 1682579)
1. Pancreatic enzyme supplement dosage in cystic fibrosis.
Owen G; Peters TJ; Dawson S; Goodchild MC
Lancet; 1991 Nov; 338(8775):1153. PubMed ID: 1682579
[No Abstract] [Full Text] [Related]
2. Comparative trial of viokase, pancreatin and Pancrease pancrelipase (enteric coated beads) in the treatment of malabsorption in cystic fibrosis.
Mitchell EA; Quested C; Marks RE; Pinnock RE; Elliott RB
Aust Paediatr J; 1982 Jun; 18(2):114-7. PubMed ID: 6923744
[No Abstract] [Full Text] [Related]
3. [Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis].
Zsíros J; Sólyom E
Orv Hetil; 1988 May; 129(19):995-9. PubMed ID: 3290773
[No Abstract] [Full Text] [Related]
4. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
Ansaldi-Balocco N; Santini B; Sarchi C
J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
[TBL] [Abstract][Full Text] [Related]
5. The pH-sensitive enteric-coated pancreatic enzyme preparations: an evaluation of therapeutic efficacy in adult patients with pancreatic insufficiency.
Dutta SK; Tilley DK
J Clin Gastroenterol; 1983 Feb; 5(1):51-4. PubMed ID: 6551402
[No Abstract] [Full Text] [Related]
6. A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis. A controlled study.
Vyas H; Matthew DJ; Milla PJ
Eur J Pediatr; 1990 Jan; 149(4):241-3. PubMed ID: 1689245
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two forms of enteric-coated pancrelipase In six teenagers with cystic fibrosis.
Warwick WJ; Budd JR
Clin Ther; 1982; 5(1):15-20. PubMed ID: 7127365
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacology for pediatricians. I. Pancreatic enzyme preparations, with special reference to enterically coated microspheres of pancrelipase.
Cho YW; Aviado DM
J Clin Pharmacol; 1981; 21(5-6):224-37. PubMed ID: 7021605
[No Abstract] [Full Text] [Related]
9. Malabsorption in cystic fibrosis: mechanisms and treatment.
Bouquet J; Sinaasappel M; Neijens HJ
J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S30-5. PubMed ID: 3404359
[TBL] [Abstract][Full Text] [Related]
10. [Long-term treatment of mucoviscidosis. Results with a microencapsulated pancreatic enzyme preparation].
Henker J; Hoffmann D; Paul D; Hein J; Paditz E
Fortschr Med; 1993 Feb; 111(4):53-6. PubMed ID: 8449468
[TBL] [Abstract][Full Text] [Related]
11. A comparison of two pancreatin microsphere preparations in cystic fibrosis.
Elliott RB; Escobar LC; Lees HR; Akroyd RM; Reilly HC
N Z Med J; 1992 Mar; 105(930):107-8. PubMed ID: 1553114
[TBL] [Abstract][Full Text] [Related]
12. [Does enzyme substitution therapy reduce pain in chronic pancreatitis?].
Hansen ML; Rumessen JJ
Ugeskr Laeger; 2005 Apr; 167(17):1841-4. PubMed ID: 15929329
[No Abstract] [Full Text] [Related]
13. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine.
Gow R; Bradbear R; Francis P; Shepherd R
Lancet; 1981 Nov; 2(8255):1071-4. PubMed ID: 6118524
[No Abstract] [Full Text] [Related]
14. Effects of pancreatic enzyme preparations on erythrocyte glutathione peroxidase activities and plasma selenium concentrations in cystic fibrosis.
Winklhofer-Roob BM; Tiran B; Tuchschmid PE; van't Hof MA; Shmerling DH
Free Radic Biol Med; 1998 Jul; 25(2):242-9. PubMed ID: 9667502
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic enzyme supplements in cystic fibrosis.
Morrison G; Morrison J; Redmond A; Byers C; McCracken K; Dodge JA
Lancet; 1991 Dec 21-28; 338(8782-8783):1596-7. PubMed ID: 1683999
[No Abstract] [Full Text] [Related]
16. Hypoalbuminemia at diagnosis as a marker for severe respiratory course in infants with cystic fibrosis identified by newborn screening.
Abman SH; Reardon MC; Accurso FJ; Hammond KB; Sokol RJ
J Pediatr; 1985 Dec; 107(6):933-5. PubMed ID: 3851839
[No Abstract] [Full Text] [Related]
17. Pancolonic disease in cystic fibrosis and high-dose pancreatic enzyme therapy.
Pettei MJ; Leonidas JC; Levine JJ; Gorvoy JD
J Pediatr; 1994 Oct; 125(4):587-9. PubMed ID: 7931879
[TBL] [Abstract][Full Text] [Related]
18. Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.
Dutta SK; Hubbard VS; Appler M
Dig Dis Sci; 1988 Oct; 33(10):1237-44. PubMed ID: 3168696
[TBL] [Abstract][Full Text] [Related]
19. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis.
Morrison G; Morrison JM; Redmond AO; Byers CA; McCracken KJ; Dodge JA; Guilford SA; Bowden MW
Aliment Pharmacol Ther; 1992 Oct; 6(5):549-55. PubMed ID: 1420747
[TBL] [Abstract][Full Text] [Related]
20. Fibrosing colonopathy in cystic fibrosis: results of a case-control study.
Smyth RL; Ashby D; O'Hea U; Burrows E; Lewis P; van Velzen D; Dodge JA
Lancet; 1995 Nov; 346(8985):1247-51. PubMed ID: 7475715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
